Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||1.41%||164.93||0.7%||$1445.32m|
|BMY||Bristol-Myers Squibb Co.||-0.70%||62.35||1.0%||$870.41m|
|MRK||Merck & Co., Inc.||0.52%||74.95||0.7%||$828.25m|
|LLY||Eli Lilly & Co.||-0.61%||203.27||1.1%||$823.19m|
|VYNE||VYNE Therapeutics, Inc.||-1.79%||8.24||0.0%||$121.21m|
|NVO||Novo Nordisk A/S||0.83%||72.83||0.1%||$92.59m|
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in BagsvÃ¦rd, Denmark.